4 Takeaways From FDA's Clinical Trial Diversity Guidance
Draft guidance from the U.S. Food and Drug Administration sheds light on how clinical trials can diversify participation and comply with new requirements to create enrollment targets for different demographic groups....To view the full article, register now.
Already a subscriber? Click here to view full article